Introduction: NEUTRALIZE-AKI is a pivotal study to evaluate the safety and effectiveness of the selective cytopheretic device (SCD) in adult patients with acute kidney injury (AKI) requiring continuous kidney replacement therapy (CKRT). Methods/Design: This is a two-arm, randomized, open-label, controlled multi-center pivotal US study which will enroll 200 adult patients (age 18–80 years) in the intensive care unit with acute kidney injury requiring CKRT and at least one additional organ failure across 30 clinical centers. Eligible patients will be randomized to CKRT plus SCD therapy versus CKRT alone. Therapy will be administered for up to 10 days, with the hypothesis that the CKRT plus SCD group will demonstrate a lower mortality rate or better rate of renal recovery than the CKRT alone group by day 90. The primary outcome is a composite of dialysis dependence or all-cause mortality at day 90. Conclusion: The SCD is a cell-directed extracorporeal therapy that targets and deactivates pro-inflammatory neutrophils and monocytes, with evidence of efficacy across a variety of critically ill patient populations. Knowledge and experience from many of those studies and other AKI trials were incorporated into the design of this pivotal study, with the aim to investigate the role of effector cell immunomodulation in the intervention of AKI.

1.
Hall
JW
,
Johnson
WJ
,
Maher
FT
,
Hunt
JC
.
Immediate and long-term prognosis in acute renal failure
.
Ann Intern Med
.
1970 Oct
73
4
515
21
.
2.
Kjellstrand
CM
,
Gornick
C
,
Davin
T
.
Recovery from acute renal failure
.
Clin Exp Dial Apher
.
1981
5
1–2
143
61
.
3.
Network
VNARFT
,
Palevsky
PM
,
Zhang
JH
,
O'Connor
TZ
,
Chertow
GM
,
Crowley
ST
.
Intensity of renal support in critically ill patients with acute kidney injury
.
N Engl J Med
.
2008 Jul 3
359
1
7
20
.
4.
Palevsky
PM
,
O’Connor
TZ
,
Chertow
GM
,
Crowley
ST
,
Zhang
JH
,
Kellum
JA
.
Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study
.
Crit Care
.
2009
;
13
(
4
):
310
.
5.
Kjellstrand
CM
,
Berkseth
RO
,
Klinkmann
H
.
Treatment of acute renal failure
. In:
Schrier
RW. GCW
, editor.
Diseases of the kidney
Boston
Little Brown
1988
. p.
1501
34
.
6.
McCarthy
JT
.
Prognosis of patients with acute renal failure in the intensive-care unit: a tale of two eras
.
Mayo Clin Proc
.
1996 Feb
71
2
117
26
.
7.
Liano
F
,
Junco
E
,
Pascual
J
,
Madero
R
,
Verde
E
.
The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group
.
Kidney Int Suppl
.
1998 May
66
S16
24
.
8.
Star
RA
.
Treatment of acute renal failure
.
Kidney Int
.
1998 Dec
54
6
1817
31
.
9.
Metnitz
PG
,
Krenn
CG
,
Steltzer
H
,
Lang
T
,
Ploder
J
,
Lenz
K
.
Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients
.
Crit Care Med
.
2002 Sep
30
9
2051
8
.
10.
Van Den Noortgate
N
,
Mouton
V
,
Lamot
C
,
Van Nooten
G
,
Dhondt
A
,
Vanholder
R
.
Outcome in a post-cardiac surgery population with acute renal failure requiring dialysis: does age make a difference
.
Nephrol Dial Transpl
.
2003 Apr
18
4
732
6
.
11.
Uchino
S
,
Kellum
JA
,
Bellomo
R
,
Doig
GS
,
Morimatsu
H
,
Morgera
S
.
Acute renal failure in critically ill patients: a multinational, multicenter study
.
JAMA
.
2005 Aug 17
294
7
813
8
.
12.
Mutunga
M
,
Fulton
B
,
Bullock
R
,
Batchelor
A
,
Gascoigne
A
,
Gillespie
JI
.
Circulating endothelial cells in patients with septic shock
.
Am J Respir Crit Care Med
.
2001 Jan
163
1
195
200
.
13.
Simmons
EM
,
Himmelfarb
J
,
Sezer
MT
,
Chertow
GM
,
Mehta
RL
,
Paganini
EP
.
Plasma cytokine levels predict mortality in patients with acute renal failure
.
Kidney Int
.
2004 Apr
65
4
1357
65
.
14.
Himmelfarb
J
,
McMonagle
E
,
Freedman
S
,
Klenzak
J
,
McMenamin
E
,
Le
P
.
Oxidative stress is increased in critically ill patients with acute renal failure
.
J Am Soc Nephrol
.
2004 Sep
15
9
2449
56
.
15.
Humes
HD
,
Sobota
JT
,
Ding
F
,
Song
JH
RAD Investigator Group
.
A selective cytopheretic inhibitory device to treat the immunological dysregulation of acute and chronic renal failure
.
Blood Purif
.
2010
;
29
(
2
):
183
90
.
16.
Ding
F
,
Song
JH
,
Jung
JY
,
Lou
L
,
Wang
M
,
Charles
L
.
A biomimetic membrane device that modulates the excessive inflammatory response to sepsis
.
PLoS One
.
2011 Apr 14
6
4
e18584
.
17.
Ayub
K
,
Hallett
MB
.
Ca2+ influx shutdown during neutrophil apoptosis: importance and possible mechanism
.
Immunology
.
2004 Jan
111
1
8
12
.
18.
Bouti
P
,
Webbers
SDS
,
Fagerholm
SC
,
Alon
R
,
Moser
M
,
Matlung
HL
.
β2 integrin signaling cascade in neutrophils: more than a single function
.
Front Immunol
.
2020
;
11
:
619925
.
19.
Ding
F
,
Yevzlin
AS
,
Xu
ZY
,
Zhou
Y
,
Xie
QH
,
Liu
JF
.
The effects of a novel therapeutic device on acute kidney injury outcomes in the intensive care unit: a pilot study
.
Am Soc Artif Intern Organs Trans J
.
2011 Sep-Oct
57
5
426
32
.
20.
Tumlin
JA
,
Chawla
L
,
Tolwani
AJ
,
Mehta
R
,
Dillon
J
,
Finkel
KW
.
The effect of the selective cytopheretic device on acute kidney injury outcomes in the intensive care unit: a multicenter pilot study
.
Semin Dial
.
2013 Sep-Oct
26
5
616
23
.
21.
Tumlin
JA
,
Galphin
CM
,
Tolwani
AJ
,
Chan
MR
,
Vijayan
A
,
Finkel
K
.
A multi-center, randomized, controlled, pivotal study to assess the safety and efficacy of a selective cytopheretic device in patients with acute kidney injury
.
PLoS One
.
2015
;
10
(
8
):
e0132482
.
22.
Johnston
KA
,
Westover
AJ
,
Rojas-Pena
A
,
Haft
JW
,
Toomasian
JM
,
Johnson
T
.
Novel leukocyte modulator device reduces the inflammatory response to cardiopulmonary bypass
.
Am Soc Artif Intern Organs Trans J
.
2019 May/Jun
65
4
401
7
.
23.
Goldstein
SL
,
Askenazi
DJ
,
Basu
RK
,
Selewski
DT
,
Paden
ML
,
Krallman
KA
.
Use of the selective cytopheretic device in critically ill children
.
Kidney Int Rep
.
2021 Mar
6
3
775
84
.
24.
Yessayan
LT
,
Neyra
JA
,
Westover
AJ
,
Szamosfalvi
B
,
Humes
HD
.
Extracorporeal immunomodulation treatment and clinical outcomes in ICU COVID-19 patients
.
Crit Care Explor
.
2022 May
4
5
e0694
.
25.
Szamosfalvi
B
,
Westover
A
,
Buffington
D
,
Yevzlin
A
,
Humes
HD
.
Immunomodulatory device promotes a shift of circulating monocytes to a less inflammatory phenotype in chronic hemodialysis patients
.
Am Soc Artif Intern Organs Trans J
.
2016 Sep-Oct
62
5
623
30
.
26.
Szamosfalvi
B
,
Puri
V
,
Sohaney
R
,
Wagner
B
,
Riddle
A
,
Dickinson
S
.
Regional citrate anticoagulation protocol for patients with presumed absent citrate metabolism
.
Kidney
.
2021 Feb 25
2
2
192
204
.
27.
Yessayan
L
,
Sohaney
R
,
Puri
V
,
Wagner
B
,
Riddle
A
,
Dickinson
S
.
Regional citrate anticoagulation "non-shock" protocol with pre-calculated flow settings for patients with at least 6 L/hour liver citrate clearance
.
BMC Nephrol
.
2021 Jul 2
22
1
244
.
28.
Zarbock
A
,
Kellum
JA
,
Schmidt
C
,
Van Aken
H
,
Wempe
C
,
Pavenstadt
H
.
Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial
.
JAMA
.
2016 May 24-31
315
20
2190
9
.
29.
Barbar
SD
,
Clere-Jehl
R
,
Bourredjem
A
,
Hernu
R
,
Montini
F
,
Bruyere
R
.
Timing of renal-replacement therapy in patients with acute kidney injury and sepsis
.
N Engl J Med
.
2018 Oct 11
379
15
1431
42
.
30.
The STARRT-AKI Investigators
.
Timing of initiation of renal-replacement therapy in acute kidney injury
.
N Engl J Med
.
2020 Jul 16
383
3
240
51
.
31.
Wald
R
,
Quinn
RR
,
Luo
J
,
Li
P
,
Scales
DC
,
Mamdani
MM
.
Chronic dialysis and death among survivors of acute kidney injury requiring dialysis
.
JAMA
.
2009 Sep 16
302
11
1179
85
.
32.
Forni
LG
,
Darmon
M
,
Ostermann
M
,
Oudemans-van Straaten
HM
,
Pettila
V
,
Prowle
JR
.
Renal recovery after acute kidney injury
.
Intensive Care Med
.
2017 Jun
43
6
855
66
.
33.
Peerapornratana
S
,
Manrique-Caballero
CL
,
Gomez
H
,
Kellum
JA
.
Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment
.
Kidney Int
.
2019 Nov
96
5
1083
99
.
34.
Park
BD
,
Faubel
S
.
Acute kidney injury and acute respiratory distress syndrome
.
Crit Care Clin
.
2021 Oct
37
4
835
49
.
35.
Group KDIGOKAKIW
.
KDIGO clinical practice guideline for acute kidney injury
.
Kidney Int
.
2012
1
138
.
36.
Davison
SN
,
Levin
A
,
Moss
AH
,
Jha
V
,
Brown
EA
,
Brennan
F
.
Executive summary of the KDIGO controversies conference on supportive care in chronic kidney disease: developing a roadmap to improving quality care
.
Kidney Int
.
2015 Sep
88
3
447
59
.
37.
Kellum
JA
,
Romagnani
P
,
Ashuntantang
G
,
Ronco
C
,
Zarbock
A
,
Anders
HJ
.
Acute kidney injury
.
Nat Rev Dis Primers
.
2021 Jul 15
7
1
52
.
38.
Vaara
ST
,
Bhatraju
PK
,
Stanski
NL
,
McMahon
BA
,
Liu
K
,
Joannidis
M
.
Subphenotypes in acute kidney injury: a narrative review
.
Crit Care
.
2022 Aug 19
26
1
251
.
39.
Zarbock
A
,
Nadim
MK
,
Pickkers
P
,
Gomez
H
,
Bell
S
,
Joannidis
M
.
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup
.
Nat Rev Nephrol
.
2023 Jun
19
6
401
17
.
40.
Camon
AM
,
Alonso
R
,
Munoz
FJ
,
Cardozo
C
,
Bernal-Maurandi
J
,
Albiach
L
.
C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19
.
Sci Rep
.
2022 Mar 28
12
1
5250
.
41.
Hung
SK
,
Lan
HM
,
Han
ST
,
Wu
CC
,
Chen
KF
.
Current evidence and limitation of biomarkers for detecting sepsis and systemic infection
.
Biomedicines
.
2020 Nov 12
8
11
494
.
You do not currently have access to this content.